CD276 and renal cell carcinoma: Next to HLA-G and PD-L1 (B7-H1) in silico analyses of RCC TCGA data also identified B7-H3, B7-H5, HVEM, CD40, CD70 and ILT2 (on tumor cells) as putative novel ICP axes (122).